A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023

Djin‐Ye Oh(Robert Koch Institute), Wiep van der Toorn(Robert Koch Institute), Andreas Nitsche(Altera (United States)), Stefan Kröger(Robert Koch Institute), Maureen Rebecca Smith(Robert Koch Institute), Michaela Niebank(Robert Koch Institute), Susanne Duwe, Martin Hölzer(Robert Koch Institute), Andrea Thürmer(Supply Chain Competence Center (Germany)), Agata Mikołajewska(Department of Science and Technology), Martin Mielke, Stephan Fuchs(Robert Koch Institute), Daniela Börnigen(Broad Institute), Janna Seifried, Walter Haas(Robert Koch Institute), Aleksandar Radonić, Sébastien Calvignac‐Spencer(Robert Koch Institute), Sindy Böttcher(Robert Koch Institute), Ralf Dürrwald(IDT Biologika (Germany)), Vanda Marujo(Institut für Hygiene und Umwelt), Matthew R. Huska(Max Delbrück Center), Janine Michel(Robert Koch Institute), Thorsten Wolff(Robert Koch Institute), Torsten Semmler, Matthias Budt(Robert Koch Institute), Marie Lataretu(Supply Chain Competence Center (Germany)), Max von Kleist(Robert Koch Institute), Romy Kerber(Robert Koch Institute), Sofia Paraskevopoulou(Robert Koch Institute)
Communications Medicine
November 11, 2025
Cited by 2


Related Papers